| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |